What's new

Buying shares?

AGL looking like a stock which will ramp all day and probably multi day story

$20m for a $4bn cancer diagnostic potential game changer ?

Also worth noting its novocellus fertility stuff an geomerics game lighting tech

have had several further bites today
 
pia786 said:
srb encouraging rns today

p.php
p.php
Click to expand...

qed
 
Matrix had 126p target before today. Some suggesting it'll go to 400p. Salt pinch etc
 
Disappointing progress from Range with regards to drilling in Georgia... God knows when they will reach TD!!
 
lovely intraday pennant typical they don't have any stock so just ramps all day long
 
pia - Its difficult to buy agl shares!! I had an order in at market for last 20 minutes... finally executed at 47!!
 
AGL over 50p and you could buy all morning at 40p and less
Albeit you had to fillorkill or put in limit orders

I will still buy more at 50p into the close I reckon.

A Daily Mail market report mention of 'cancer game changer' usually causes 100% plus moves and this one actually warrants it
 
Last edited:
So they have a $30m market cap and reckon they are targetting a circulating tumour cell diagnostic market opp in US alone of $4bn ? PER ANNUM

There will be some prepared to pay over 100p when they hear this in tomorrows papers

Kicking myself for not buying loads more this morning

Thick t**t
 
Last edited:
pia786 said:
AGL over 50p and you could buy all morning at 40p and less
Albeit you had to fillorkill or put in limit orders

I will still buy more at 50p into the close I reckon.

A Daily Mail market report mention of 'cancer game changer' usually causes 100% plus moves and this one actually warrants it
Click to expand...

market cap around £20m...... this might go over 100 in the next few days
 
pia786 said:
So they have a $30m market cap and reckon they are targetting a circulating tumour cell diagnostic market opp in US alone of $4bn ? PER ANNUM

There will be some prepared to pay over 100p when they hear this in tomorrows papers

Kicking myself for not buying loads more this morning

Thick t**t
Click to expand...

I only bought 5000 shares!!
 
Johnson and Johnson have reportedly spent $200m on their CTC chip technology which would be an AGL share price of circa 350p per share!
 
I will be at next weeks Angle AGM in Guildford. Really looking forward to it now.
 
EE to be honest first bought AGL for Novocellus that improves probability of success in IVF.

Some potentially life changing stuff AGL are working on. they were early on PXS too.
 
Pretty hopeful of a big continuation day in AGL tomorrow.

If I was reading the overnight press and new to story I'd be saying $40m market cap for a company looking to serve unmet medical need in the $4000m p.a. cancer diagnostic market this has hallmarks of not just a ten bagger but potential hundred bagger!

Also bear in mind Geomerics and Novocellus company makers in their own right.

With AGM next Thursday scope for continuation of newsflow on all aspects of AGL business in coming days/weeks
 
Have you guys read MST RNS?

I bought some this morning to add to previous

They used to talk about orders of 4000 now 75000!!!

Talk of placing might keep lid on it but that is huge.
 
Thanks for mentioning it here yesterday...... In the long run, AGL has success written all over it and I will buy back with a much larger holding once people have taken profit.
 
AGL resilient performance today

MST has been ignored but I read the RNS again and it sure reads well. Wonder if Bulford will tip it in RHPS? It was definitely on his radar.
 
If anyone is free next Thursday 2pm Guildford come along to AGL AGM should be something for everyone... computer gaming fans, medical cancer diagnostics, IVF fertility solutions and nice biccies !
 
GMA total disaster always the way with these highly indebted situations completely binary
 
AGL looking good.

I'd love to buy more but trying not letting short term price movement impact my judgement.

Will wait for AGM and chance to see 'whites of their eyes'
 
pia - Ask the BOD about their plans for personalised medicine (cancer in particular) via human genome sequencing........
 
AGL Navid Malik the analyst at Merchant Securities who was at Matrix (where he put out the 126p price target research note) has Initiated Coverage at Merchant with a 119p target

I think AGL has several potential company making investments but has been off the radar for years (Management have loads of options at 80p and over 100p) so any news from other aspects over coming weeks will see massive reappraisal of the value.

Expecting well over 100p by end of year there. In a market which is otherwise dying I reckon you have to run your winners.
 
pia786 said:
Is there a link for that EE ?

RHPS looks a bit of a tepid selection again.
Click to expand...

Its on the market roundup section. They always have 3 shares for buy/sell/hold.

It was in the market round up page but cannot find it on their site. But I have done a screen scrape from the e-edition of standard today.....
angle_evening_standard.jpg
 
Thanks. A lot of potential catalysts for AGL going forward.

3M / Acolyte court case resolution

Geomerics - Release of Battlefield 3 and NVIDIA milestones?

Novocellus - progress in IVF fertility trials

Parsortix - cancer diagnostics partnerships/validation
 
pia - whats happening over at SRB? mcap now under £10m... downward trend for sometime or news in the pipeline soon?
 
Everything is in a downtrend! Brokers recently initiated coverage with a decent sized note with price target of 49p and success case potential of 90p+

Management options c.40p

Eldorado own 26% and paid 30p

At 15p I'd say it was too cheap and finally has some chart support here.

I have loads but will buy more here. Would be nice to see Management step up to the plate.

If Eldorado do want to take over they only have to call one person who owns 23%.
 
Last edited:
Oracle Coalfields (ORCP) appoints Citigroup as Financial Advisers for Thar Coal project in Pakistan.

Commenting on the appointment of Citi, Shahrukh Khan, CEO of Oracle Coalfields said:

"After careful consideration and having looked at a number of international banks, we are delighted to have appointed Citi. The appointment will add to our financial expertise and market coverage as we evolve to the next stage of development with an excellent team of financial advisors to guide us.

"The Company remains fully committed to the development of Block VI, Thar Coal Project and continues to receive support from the Pakistani Government at all levels, all of whom recognise the positive economic and infrastructure impact our project will have on the country."

Arif Usmani, Managing Director and Citi Country Officer for Pakistan added: "We are delighted to be selected as the financial advisor to Oracle Coalfields for the development of this important project. Citi has been operating in Pakistan since 1961 with an on-the-ground team of dedicated corporate and investment bankers. Citi looks forward to assisting Oracle with the financing for the next stage of its development."
 
IGE Imagescan RNS looks worth a read this morning.

Mkt Cap £2m. Cash £1m. Order book £4m.

They do 3D X-ray scanners for Security and Industrial use.
 
They seem to be doing what Serabi are doing. They have a couple mineable areas and an area in between which may have mineable ore and they are doing high level first pass skim over the area to see which areas are worth targetting for drilling. It is quite early stage. The share price reaction today is simply investors not understanding the bigger picture.
 
SRX - I reckon 80p+ which is why PALA are trying to nick it for 40p or less gives them lots of upside still paying 30p for the 60% they don't own. Stealing it.
 
IGE

Order Intake level growth and Order Book growth impressive.

Order Intake level (bear in mind at different points of year and over different deliverable periods)

25th March 2010 : £0.8m
17th March 2011 : £1.56m
3rd October 2011 : £4.3m

Order Book level :

8th October 2010 : £0.1m
24th January 2011 : £1.3m
3rd October 2011 : £2.3m
 
SRX - not sure what PALA game is, they aren't operators so maybe just trying to call the bluff of Kenmare or Iluka ?
 
pia786/Eagle_Eye,

I thought I'd never say this but I will go so far as to say that Orogen Gold is overrated. There are far better gold plays out there. The company is at a very early stage and isn't going to go anywhere fast, however the sell off today is just people panicking and wanting out. The funding issue is a big concern and the fact that production could be a few years away? I will continue to hold though and see what happens but the interest in this company is slowly being obliterated by the day.
 
Angle AGL are going to host an investor webcast on Friday. Should be illuminating and keep it in investors minds. Maybe management think shares haven't gone up enough to reflect true potential?
 
Sorry for the noob question so deep into the thread, but was just wondering (pia786 or anyone else experienced in the sharemarket), what type of initial capital you think is a requirement to begin investing in the market? I know the share returns are not high and are long term investments as opposed to other types of investment; but would a slow accumulation of shares be more advisable as opposed to saving a lot of capital and investing in one go?
 
Poison,

Look at it this way... how much can you afford to put away (or lose) and NOT have your life style be affected? You work out the sums from then on. In a downward market like today where there is so much uncertainty around, the best thing is to actually not be invested. You will be in fortunate position of not being tied up in share and lying in wait when the sentiment does turn.

On the specifics of how much capital... well it depends on your strategy and which companies you invest and whether fees are not eating too much of the invested amount. In large multilaterals on the main exchange, the price will go up or down much slowly with a smaller spread between the and sell price compared to those say who are high risk oil explorers. Generally, its a good idea not to invest all in one go as that does not give you the ability for a comeback if your investment does go belly up.
 
pia - are you going to AGL agm? brief report would be appreciated if you do... I will try to log onto the webcast on Friday.
 
Parsortix will have competition from some of the bigger players in the area of cell capture from circulating blood.....

Illumina have plans for such a product.... see excerpt below

Are Angle in a hurry to get their product out to research institutes before Illumina does in 2012?

Could Illumina's rivals like Roche and lifetechnology want Parsortix to integrate within their sequencing technologies in order to compete with Illumina?.......


Illumina expects results from its ovarian cancer biomarker study in early 2012 and is working on capturing ovarian cancer cells from body fluids, a company executive said last week.

The company also asserted that the MiSeq platform, to be commercialized later this year, will be suitable for diagnostic applications in cancer and other areas.

Illumina started its Cancer Discovery Initiative two years ago, focusing initially on ovarian and gastric cancer. Earlier this year, it added colorectal cancer to the program. Using next-generation sequencing, the company aims to discover biomarkers for early disease detection and prediction of therapy response or relapse, and to develop these markers into diagnostic tests.

Earlier this year, Illumina president and CEO Jay Flatley said the company is in the midst of validating ovarian cancer genes detected in 25 tumor-normal pairs by targeted sequencing in about 300 samples, a project to be completed by mid-year, with results expected by the end of the year (IS 1/18/2011).

During Illumina's first-quarter earnings call last week, Flatley revised this timeline slightly, saying that validation should be mostly completed by the end of the third quarter, and analysis by the end of the year, so "somewhere probably in Q1 [of 2012], we'll know what we have there."

In addition, as part of an effort to translate the results to the clinic, the company is applying a rare cell capture technology to see if it can detect ovarian cancer cells in body fluids. Those studies are "a very important part" of Illumina's translational work in ovarian cancer, Flatley said.

Illumina developed the proprietary rare cell capture technology in house (IS 1/18/2011) and plans to start offering it to third parties through its sequencing service business in the second quarter, he added.

The firm's gastric cancer biomarker discovery project is "three to five months behind" the ovarian cancer project, with validation sequencing ongoing, while the colorectal cancer project is "in the initial sequencing phases now," he said.

http://www.genomeweb.com/sequencing...arian-cancer-program-expects-clinical-apps-mi
Click to expand...
 
It's all double dutch to me. I'll be attending the AGM and will report back on the areas within my competence which may just be an opinion on the quality of biscuits.
 
I've no real facts to back this up just an anecdotal observation but the rarely traded micro caps seem to have held up well in this years carnage? I am thinking of the likes of IGE and MST which aren't in 'hot' areas like oil or metals.

Much of recent falls seem to be in crowded trades where margin calls on over leveraged traders leads to vicious spirals down.
 
Biscuits... nice. Coffee not so much.

Unfortunately no inside information got spilled out in my direction at Frederick Sanger Road but the confidence of the management is obvious. AGL CEO owns 20% of the equity in his company his interests are aligned with shareholders so there won't be silly and superfluous equity dilution.

Parsortix is garnering all the headlines but Geomerics and Novocellus should not be ignored. There should be nearer term newsflow on Geomerics as Battlefield 3 launch is imminent.

I got a good feeling from SUMM AGM at what 4p and it went to 14p and still strong now at 8p. I am even more buzzed about AGL because it has 3 potential global technologies partnered with industry leaders which should help establish them quickly if they do get proved up to commercial standard.
 
Last edited:
It doesn't look promising, does it? All the rumours last week suggested a big gusher, but the buying patterns just didn't support that theory.

I am lucky to be in from the 3's so will hold for now.
 
All signs are pointing towards that. It seems they are giving it one last shot with VSP to see what lies beneath the granite rock....

RMP have already announced placing for select investors around the Agm time 4 November. Will they keep us guessing till then or they banking on news from punt land to get things moving in the right direction.

My average is around 8.5 with rrl so keeping a very close eye on things for now.. Down in rmp but it's a much smaller stake.
 
Quiet a discussion we got going here.I don't know how I missed this thread.I didn't know we had some investors here at PP :D.
What do you guys make of BAC and Sprint stocks ?they look really really tempting right now for a long term investment.BAC itself is in DOW 30 and sprint has been making a lot of teh right moves.Should i jump or wait for them to bottom out ?
 
Most of the regulars here are into UK shares.

Maybe Godzilla could espouse on US stocks such as the ones you mentioned ?
 
Offers flying in ...... First Encore and now DPL..... Who is next?
 
Last edited:
Ones with decent production but also explo upside

LHD Lochard formerly Rheochem in frame late today
FPM?
MATD?
RKH ?
 
Last edited:
NPE?
COV?

again production and explo potential makes NPE interesting
 
Last edited:
Bottled it yesterday and sold half of my RRL and all of RMP holding....... what a kick a in the teeth today :)

Jaspa did you togth it out?
 
You must log in or register to reply here.

Similar threads

Hitman
Vietnam tycoon Truong My Lan sentenced to death in $12.5bn fraud case
Replies
3
Views
350
gazza619
gazza619
FearlessRoar
Pakistan’s top talent is leaving the country in record numbers
Replies
2
Views
149
big_gamer007
big_gamer007
MenInG
Record-breaking summit of K2 dogged by allegations that Western climbers left Pakistani man to die
Replies
19
Views
961
Cricket Warrior
C
The Bald Eagle
"Revamp it, revisit it and play it the way white ball cricket should be played": Imad Wasim
Replies
41
Views
2K
shamaan
S
Asad T
[VIDEO] "Match-fixing is still happening" Jarrod Kimber and David Lloyd
Replies
34
Views
2K
sweep_shot
sweep_shot
Back
Top